Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-30T20:06:57.218Z Has data issue: false hasContentIssue false
  • English
  • Français

Preventing Clostridium difficile–Associated Disease: Is It Time to Pay the Piper?

Published online by Cambridge University Press:  02 January 2015

Eli N. Perencevich  and
Kerri A. Thom
Eli N. Perencevich*
Affiliation:
Veterans Affairs Maryland Health Care System, Baltimore, Maryland
Kerri A. Thom
Affiliation:
Veterans Affairs Maryland Health Care System, Baltimore, Maryland Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland
*
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 100 N. Greene Street, Lower Level, Baltimore, MD 21201 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 9 , September 2008 , pp. 829 - 831
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Klevens, RM, Edwards, JR, Richards, CL Jr., et al.Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160–166.Google Scholar
2.Stone, PW, Braccia, D, Larson, E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005;33:501–509.Google Scholar
3.Rosenthal, MB. Nonpayment for performance? Medicare's new reimbursement rule. N Engl J Med 2007;357:1573–1575.Google Scholar
4.Medicare program. Proposed changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates. Vol. 73. Federal Register, 2008:23527–23576.Google Scholar
5.Harbarth, S, Sax, H, Gastmeier, P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003;54:258–266.Google Scholar
6.Barbut, F, Gariazzo, B, Bonne, L, et al.Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000–2004. Infect Control Hosp Epidemiol 2007;28:131–139.Google Scholar
7.Svenungsson, B, Burman, LG, Jalakas-Pornull, K, Lagergren, A, Struwe, J, Akerlund, T. Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-transmission in a Swedish teaching hospital. J Clin Microbiol 2003;41:4031–4037.CrossRefGoogle Scholar
8.Clabots, CR, Johnson, S, Olson, MM, Peterson, LR, Gerding, DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166:561–567.Google Scholar
9.Riggs, MM, Sethi, AK, Zabarsky, TF, Eckstein, EC, Jump, RL, Donskey, CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007;45:992–998.Google Scholar
10.Harbarth, S, Samore, MH, Carmeli, Y. Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. J Hosp Infect 2001;48:93–97.Google Scholar
11.Boyce, JM, Pittet, D; Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002;51(RR-16):1–45.Google ScholarPubMed
12.O'Brien, JA, Lahue, BJ, Caro, JJ, Davidson, DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28:1219–1227.Google Scholar
13.McDonald, LC, Owings, M, Jernigan, DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006;12:409–415.Google Scholar
14.Kyne, L, Hamel, MB, Polavaram, R, Kelly, CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346–353.CrossRefGoogle ScholarPubMed
15.Dubberke, ER, Reske, KA, Olsen, MA, McDonald, LC, Fraser, VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008;46:497–504.Google Scholar
16.Lawrence, SJ, Puzniak, LA, Shadel, BN, Gillespie, KN, Kollef, MH, Mundy, LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007;28:123–130.Google Scholar
17.Song, X, McDonald, LC, Bartlett, JG, et al.The rising economic impact of Clostridium difficile-associated disease in adult hospitalized patients. Infect Control Hosp Epidemiol 2008;29:823–828 (in this issue).Google Scholar
18.McGregor, JC, Rich, SE, Harris, AD, et al.A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 2007;45:329–337.Google Scholar
19.Cosgrove, SE, Carmeli, Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003;36:1433–1437.Google Scholar
20.Pepin, J, Saheb, N, Coulombe, MA, et al.Emergence of fluroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254–1260.Google Scholar
21.McCusker, ME, Harris, AD, Perencevich, E, Roghman, MC. Fluroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 2003;9:730–733.Google Scholar
22.Perencevich, EN, Stone, PW, Wright, SB, Carmeli, Y, Fisman, DN, Cosgrove, SE. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007;28:1121–1133.Google Scholar
23.Ward, WJ, Spragens, L, Smithson, K. Building the business case for clinical quality. Healthc Financ Manage 2006;60:92–98.Google Scholar